In a study published in the New England Journal of Medicine, researchers at the UC San Diego School of Medicine and Moores Cancer Center at UC San Diego Health found the combination of immunotherapy and chemotherapy in patients with advanced endometrial cancer resulted in a significant reduction in disease growth when compared with chemotherapy alone.